Archer well-capitalised, development advancing

Good morning, in this edition of Archer’s Newsletter, we highlight the Company’s financial position and second quarter activities.

At Archer we are well funded into the foreseeable future with approximately A$24 million cash and no debt.

We have a focus on technology development at the cutting edge in a growing, critical industry, and we are working towards commercialisation of advanced technologies by protecting our IP and by partnering with global players both small and large.

We have been resourceful with available cash while continuously working to put Archer in a better position to deliver on our strategy. Significant advances made in 12CQ quantum chip development, and the major milestone achieved towards commercialisation of Archer’s biochip technology, testify to this efficiency.

Archer staff have continued their dedicated and focused work in the year. We are growing a highly capable team with strong and deep technical expertise to drive the Company’s development, and I look forward to updating you on our progress and the exciting opportunities ahead of us.

Sincerely,

Dr Mohammad Choucair, FRACI FRSN GAICD
Chief Executive Officer
Archer Materials Limited (ASX: AXE)

Click here to view the full Newsletter